Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurobeachin pseudogene 1 (NBEAP1) is a non-functional pseudogene derived from the coding gene "Neurobeachin" (NBEA). Pseudogenes are DNA segments resembling known genes but lacking the ability to produce functional proteins. NBEAP1 does not have an established role in human physiology or disease and is not considered a molecular target for therapeutic intervention. Most published research and biological characterization address the functional protein Neurobeachin, a multidomain BEACH domain-containing protein crucial for synaptic vesicle trafficking, neurotransmitter release, and synapse formation in neuronal tissues[1][2][3]. If structured information about a legitimate therapeutic or research target is needed, users should refer to the Neurobeachin coding gene (NBEA), not the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurobeachin pseudogene 1 (NBEAP1).